Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Study Reveals Why Older Adults Are Using Cannabis Edibles | University of Utah Health (opens in a new tab)

healthcare.utah.edu · 2026-05-08

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

3 claims go further than the study. 4 other points were not covered by the paper.

  • 1 supported
  • 3 overstated
  • 4 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

Three of eight claims overstate the study. One of eight checks out. Four claims the study doesn't address.

  • 1 supported
  • 3 overstated
  • 4 not covered
Open claim evidence
3
Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

8 claims in this story

Showing all 8 claimsChoose a verdict to focus the list.

Claim 1 of 8OverstatedA new study by researchers from University of Utah Health and University of Colorado Boulder found that many older adults start cannabis seeking more effective or non-pharmaceutical options to manage sleep, pain, or mental health, and that many base decisions on word of mouth rather than discussions with health care providers.View evidenceHide evidence

As stated169 adults over 60 were interviewed

Why this verdict

The paper supports that 169 older adults reported motivations such as avoiding pharmaceuticals, having exhausted other options, new or worsening problems, and beliefs/evidence of benefit for sleep, pain, or mental health. However, the abstract-level profile does not verify the story’s added claims that many decisions were based on word of mouth rather than discussions with health care providers, and the causal framing that word of mouth drove decisions is stronger than the available evidence.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
Claim 2 of 8OverstatedThe researchers interviewed 169 adults over 60 who were about to purchase cannabis for the first time to identify common motivations.View evidenceHide evidence

As stated169 adults over 60

Why this verdict

The abstract supports that 169 adults aged 60 or older in Colorado completed pre-purchase semistructured interviews about motivations for edible cannabis use. It does not verify that they were purchasing cannabis for the first time; the profile describes them as interested in edible cannabis and interviewed before purchasing one of three product types.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
2

Study evidence

Distribution of product-type selections among 169 interviewed older adult participants: 96 (57.5%) chose a THC+CBD combination edible; 48 (28.7%) chose a CBD-dominant edible; 23 (13.8%) chose a THC-dominant edible.96 (57.5%); 48 (28.7%); 23 (13.8%)

“Among 169 participants... 96 (57.5%) selected a THC and CBD combination product, 48 (28.7%) selected a CBD-dominant product, and 23 (13.8%) selected a THC-dominant product.”
Claim 3 of 8OverstatedMany people perceived CBD-only products as therapeutically beneficial, often driven by anecdotal claims, while THC was perceived as offering benefits like improving mood; most people chose combination products containing both, seeing them as a 'Goldilocks option'.View evidenceHide evidence

Why this verdict

The paper supports that participants perceived claims/evidence of benefit across product types, that combination THC+CBD products were most commonly selected, and that combinations were perceived as potentially offering dual benefits. However, the abstract-level profile does not verify anecdotal drivers for CBD perceptions, THC benefits such as improving mood, the exact “Goldilocks option” framing, or that products were strictly CBD-only/THC-only rather than CBD-dominant/THC-dominant.

1

Study evidence

Participants perceived evidence or claims of benefit as a positive attribute for all three cannabinoid profile types (CBD-dominant, THC-dominant, THC-CBD combination).

“...to understand how they perceive the benefits and drawbacks of different cannabinoid profiles: cannabidiol (CBD)-dominant, tetrahydrocannabinol (THC)-dominant, or a THC-CBD combination product.”
2

Study evidence

Distribution of product-type selections among 169 interviewed older adult participants: 96 (57.5%) chose a THC+CBD combination edible; 48 (28.7%) chose a CBD-dominant edible; 23 (13.8%) chose a THC-dominant edible.96 (57.5%); 48 (28.7%); 23 (13.8%)

“Among 169 participants... 96 (57.5%) selected a THC and CBD combination product, 48 (28.7%) selected a CBD-dominant product, and 23 (13.8%) selected a THC-dominant product.”
Claim 4 of 8Not coveredFor adults over 60, cannabis use is increasing faster than in any other demographic.View evidenceHide evidence

As statedincreasing faster than in any other demographic

Why this verdict

The abstract-level profile says older adults are a rapidly growing group of cannabis users, but it does not substantiate the stronger headline claim that use is increasing faster than in any other demographic. The headline therefore outruns the paper evidence available at this depth.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
Claim 5 of 8Not coveredMany participants had heard positive anecdotes about product usefulness from friends or family members, and those anecdotes tended to influence decisions.View evidenceHide evidence

Why this verdict

The abstract-level profile reports that participants cited claims/evidence of benefit, but it does not specify positive anecdotes from friends or family, nor does it establish that those anecdotes influenced decisions. This may require full-text evidence.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
Claim 6 of 8Not coveredDiscussions with medical providers were rarely part of the picture, suggesting that better informational materials for patients and providers may be needed.View evidenceHide evidence

Why this verdict

The profile supports a general discussion point that clinician awareness and counseling resources may be needed. But the abstract-level evidence does not verify the specific claim that discussions with medical providers were rarely part of participants’ decision-making.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
2

Study evidence

Participants perceived evidence or claims of benefit as a positive attribute for all three cannabinoid profile types (CBD-dominant, THC-dominant, THC-CBD combination).

“...to understand how they perceive the benefits and drawbacks of different cannabinoid profiles: cannabidiol (CBD)-dominant, tetrahydrocannabinol (THC)-dominant, or a THC-CBD combination product.”
Claim 7 of 8Not coveredThe article says the research was published in JAMA Network Open as 'Edible Cannabis and Pain, Sleep, and Mental Health Management in Older Adults.'View evidenceHide evidence

Why this verdict

The supplied paper profile includes a PMID but does not provide journal-title metadata sufficient to verify publication in JAMA Network Open or the exact article title at this evidence depth.

Claim 8 of 8SupportedThe survey was conducted in Colorado, where recreational cannabis is legal, and the article says the decision-making process may look different in Utah and other states where only medical use is permitted.View evidenceHide evidence

Why this verdict

The profile supports that the study was conducted in Colorado and that the single-state setting limits generalizability. The specific Utah/legal-regime comparison is not detailed in the abstract-level profile, but the story’s hedged point that decision-making may differ elsewhere is consistent with the stated generalizability limitation.

1

Study evidence

Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.

“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
2

Study evidence

Distribution of product-type selections among 169 interviewed older adult participants: 96 (57.5%) chose a THC+CBD combination edible; 48 (28.7%) chose a CBD-dominant edible; 23 (13.8%) chose a THC-dominant edible.96 (57.5%); 48 (28.7%); 23 (13.8%)

“Among 169 participants... 96 (57.5%) selected a THC and CBD combination product, 48 (28.7%) selected a CBD-dominant product, and 23 (13.8%) selected a THC-dominant product.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • Perceived benefits and drawbacks differed by cannabinoid profile: THC-containing products raised impairment concerns; CBD-dominant products were viewed as having limited efficacy; combination products raised THC:CBD ratio uncertainty.

    The story emphasizes perceived benefits and the “Goldilocks” appeal of combination products, but it does not reflect the abstract’s important drawbacks and trade-offs, especially impairment concerns, limited perceived CBD efficacy, and uncertainty about ideal ratios.

    From Qualitative semistructured interviews (pre-purchase)

  • The findings are based on self-reported, pre-purchase perceptions rather than measured clinical outcomes or post-use experiences.

    The story generally describes perceptions and motivations, but its caveats do not clearly state that the evidence is pre-use, self-reported, and not evidence of actual therapeutic effectiveness.

    From Qualitative semistructured interviews (pre-purchase)

  • Convenience sampling and participant self-selection limit representativeness.

    The story mentions the Colorado setting but does not acknowledge that participants were a convenience/self-selected sample of older adults already interested in edible cannabis, an interpretation-changing limitation for generalizing the findings.

    From Qualitative semistructured interviews (pre-purchase); Convenience sampling; descriptive counts/percentages

6 things the story did carry across
  • Community-based qualitative study of adults aged 60 or older in Colorado using pre-purchase semistructured interviews about edible cannabis use for sleep, pain, or mental health.
  • Sample size and pre-purchase product-choice context: 169 participants interviewed before purchasing one of three edible product types.
  • Common motivations included avoiding pharmaceuticals, having exhausted other options, new or increasing problems, and beliefs/evidence of benefit.
  • Product selection distribution: 57.5% selected THC+CBD combination, 28.7% CBD-dominant, and 13.8% THC-dominant products.
  • Single-state Colorado setting limits generalizability.
  • Need for clinician awareness and counseling/resources regarding older adults’ edible cannabis motivations and concerns.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

3

Evidence read

study summary

Lead result

human in vivo

1Lead resulthuman in vivoCharacterize older adults’ motivations for using edible cannabis to manage sleep, pain, or mental health symptoms, based on pre-purchase semistructured interviews in Colorado.Community-based qualitative study with semistructured individual interviewsExpand

In plain English

Community-based qualitative study of adults aged ≥60 in Colorado using pre-purchase semistructured interviews (audio-recorded, transcribed, and analyzed) to characterize motivations for selecting edible cannabis products for sleep, pain, or mental health. Among 169 participants (mean age 70.8 years, 54% female) interviewed between November 2021 and November 2023, common motivations included avoiding pharmaceuticals, having exhausted other options, new or worsening problems, and beliefs/evidence of benefit. Participants selected one of three edible product types before purchase (THC+CBD combination, CBD-dominant, or THC-dominant); combination products were most commonly chosen. Perceived benefits were associated with claims/evidence for all product types; main drawbacks were concern about getting high/being impaired for THC-containing products and perceived limited efficacy for CBD products. Combination products were seen as potentially offering dual THC-CBD benefits but posed challenges in determining ideal ratios.

Key findings

  • Older adults reported motivations for using edible cannabis that included avoiding pharmaceuticals, having exhausted other options, new or increasing health problems, and beliefs or evidence of potential benefit.
  • Among 169 participants (mean age 70.8 years; 54% female), 57.5% (96) selected a THC+CBD combination product, 28.7% (48) selected a CBD-dominant product, and 13.8% (23) selected a THC-dominant product when offered a choice prior to purchase.n=169; 96 combination (57.5%), 48 CBD-dominant (28.7%), 23 THC-dominant (13.8%); mean age 70.8 (SD 5.8); 54% female
“This community-based, qualitative study was study conducted in Colorado from November 2021 to November 2023”
2human in vivoDescribe perceived benefits and drawbacks of different edible cannabinoid profiles (CBD-dominant, THC-dominant, THC-CBD combination) as reported by older adults prior to purchase.Qualitative semistructured interviews (pre-purchase)Expand

In plain English

Qualitative analysis of pre-purchase perceptions among older adults (n=169) about benefits and drawbacks of three edible cannabis cannabinoid profiles (CBD-dominant, THC-dominant, THC-CBD combination). Participants completed semistructured interviews before selecting one of three edible product types; themes compared across product-type selections focused on perceived outcomes and concerns associated with each cannabinoid profile.

Key findings

  • Participants perceived evidence or claims of benefit as a positive attribute for all three cannabinoid profile types (CBD-dominant, THC-dominant, THC-CBD combination).
  • The most common perceived drawback for THC-dominant products was concern about getting high or being impaired.23 of 169 (13.8%) selected THC-dominant products; concern about impairment reported as the primary drawback for THC products.
“...to understand how they perceive the benefits and drawbacks of different cannabinoid profiles: cannabidiol (CBD)-dominant, tetrahydrocannabinol (THC)-dominant, or a THC-CBD combination product.”
What this piece can’t prove
  • Convenience sample of older adults in Colorado limits generalizability.
  • Data reflect pre-purchase, self-reported perceptions rather than measured clinical outcomes or post-use experiences.
  • Abstract provides limited detail on analytic methods and theme quantification; counts are provided for product selections but not for frequency of specific perceived benefits/drawbacks.
3human in vivoDescribe participants’ selection distribution across the three edible product types (CBD-dominant, THC-dominant, combination) in this qualitative, convenience sample.Convenience sampling; descriptive counts/percentagesExpand

In plain English

In this convenience sample of 169 adults aged 60 years or older in Colorado who were interested in using edible cannabis and who completed an interview prior to purchasing a product, 96 (57.5%) selected a THC+CBD combination edible, 48 (28.7%) selected a CBD-dominant edible, and 23 (13.8%) selected a THC-dominant edible.

Key findings

  • Distribution of product-type selections among 169 interviewed older adult participants: 96 (57.5%) chose a THC+CBD combination edible; 48 (28.7%) chose a CBD-dominant edible; 23 (13.8%) chose a THC-dominant edible.96 (57.5%); 48 (28.7%); 23 (13.8%)
“Among 169 participants... 96 (57.5%) selected a THC and CBD combination product, 48 (28.7%) selected a CBD-dominant product, and 23 (13.8%) selected a THC-dominant product.”
What this piece can’t prove
  • Convenience sampling and participant self-selection limit representativeness of the findings.
  • Descriptive counts reflect choices in this enrolled sample and do not imply effectiveness or preference causality.
  • Single-state setting (Colorado) and the specific enrollment period may limit broader generalizability.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 15 candidate papers

And 9 more candidates considered.